| Literature DB >> 11029514 |
D M Smith1, G Gao, X Zhang, G Wang, Q P Dou.
Abstract
Understanding how current chemotherapeutic modalities induce apoptosis is critical to designing better anti-cancer agents. This review is concerned with how pharmacological agents induce tumor cell apoptosis in a cell cycle-dependent manner. Recent experiments demonstrate that expression of several apoptotic regulatory proteins (such as Bcl-2, Bax, p53, and Survivin) are differentially regulated according to the phases of the cell cycle. This cell cycle-dependent regulation in turn contributes to increased drug sensitivity in different phases of the cell cycle. It is therefore likely that the cell cycle-dependent expression of cell death proteins plays a role in regulating chemosensitivity and apoptotic commitment of human tumor cells.Entities:
Mesh:
Substances:
Year: 2000 PMID: 11029514 DOI: 10.3892/ijmm.6.5.503
Source DB: PubMed Journal: Int J Mol Med ISSN: 1107-3756 Impact factor: 4.101